AHMED NADIM

CIK 00017311934 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001731193

Recent Transactions

50 trades

Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2026-02-24$14.47/sh−13,515→ 390,803 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2026-02-20$13.62/sh−16,381→ 404,318 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2026-02-18+828,000→ 828,000 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2025-07-14+20,000→ 20,000 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-25$8.53/sh−12,529→ 430,621 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-19+180,000→ 443,150 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-02-19+360,000→ 360,000 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-12-24$11.87/sh−8,400→ 263,150 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-02-22+320,000→ 320,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-22+160,000→ 271,550 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-26$9.24/sh−4,272→ 111,550 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-28$11.40/sh−759→ 115,822 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-05-23$9.15/sh−707→ 116,581 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-04-25$10.59/sh−716→ 117,288 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-03-23$10.51/sh−706→ 118,004 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-02-22+211,000→ 211,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-02-22+109,000→ 118,710 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-06-30$10.90/sh+1,620→ 9,710 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-06-06$12.40/sh+8,090→ 8,090 total
Award
Cullinan Therapeutics, Inc.$CGEM
Performance Stock Unit
2022-03-05+215,000→ 215,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2021-10-18+2,710,000→ 2,710,000 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-12-31+14,946→ 46,549 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-12-31$62.03/sh−7,660→ 38,889 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-12-31−14,946→ 0 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-12-02$62.18/sh−3,380→ 31,603 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-12-02−6,594→ 19,782 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-12-02+6,594→ 34,983 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-10-30$58.45/sh−2,291→ 28,389 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-10-30−4,650→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-10-30+4,650→ 30,680 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-05-01+2,908→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-05-01+2,908→ 27,463 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-05-01$60.26/sh−1,433→ 26,030 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2020-03-10+21,388→ 21,388 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2020-03-10+32,082→ 32,082 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-03-01+17,204→ 34,410 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-03-01+17,204→ 33,028 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-03-01$59.06/sh−8,473→ 24,555 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2020-02-04+2,076→ 4,152 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-02-04+2,076→ 16,895 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2020-02-04$64.29/sh−1,071→ 15,824 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2019-12-02+26,376→ 26,376 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2019-11-20+13,949→ 13,949 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2019-11-20+7,440→ 7,440 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2019-11-20+1,966→ 1,966 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2019-11-20+14,946→ 14,946 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2019-11-20+2,908→ 2,908 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2019-11-20+19,621→ 19,621 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2019-11-20+9,299→ 9,299 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2019-11-20+9,350→ 9,350 total

AHMED NADIM

Recent Transactions

Companies

Recent Filings

Address